thiamine has been researched along with Hearing Loss, Sensorineural in 57 studies
thiamine(1+) : A primary alcohol that is 1,3-thiazol-3-ium substituted by (4-amino-2-methylpyrimidin-5-yl)methyl, methyl and 2-hydroxyethyl groups at positions 3, 4 and 5, respectively.
Hearing Loss, Sensorineural: Hearing loss resulting from damage to the COCHLEA and the sensorineural elements which lie internally beyond the oval and round windows. These elements include the AUDITORY NERVE and its connections in the BRAINSTEM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thiamine-responsive megaloblastic anemia (TRMA) syndrome is an autosomal recessive inherited disorder characterised by a triad of megaloblastic anemia, diabetes mellitus, and sensorineural deafness." | 7.88 | Thiamine Responsive Megaloblastic Anaemia, Diabetes Mellitus and Sensorineural Hearing Loss in a Child. ( Altaf, C; Fatima, S; Khadim, MT; Khurshid, A; Malik, HS; Sajjad, Z, 2018) |
| " Arrhythmia in thiamine responsive megaloblastic anemia syndrome." | 7.88 | Arrhythmia in thiamine responsive megaloblastic anemia syndrome. ( Akın, L; Argun, M; Baykan, A; Hatipoğlu, N; Kurtoğlu, S; Narin, N; Şahin, Y, 2018) |
| "Thiamine responsive megaloblastic anemia syndrome (TRMA) is a clinical triad characterized by thiamine-responsive anemia, diabetes mellitus and sensorineural deafness." | 7.75 | Thiamine responsive megaloblastic anemia syndrome. ( Ezhilarasi, S; Ganesh, R; Gowrishankar, K; Rajajee, S; Vasanthi, T, 2009) |
| "Thiamine-responsive megaloblastic anemia (TRMA) syndrome is an autosomal recessive disorder characterized by diabetes mellitus (DM), progressive sensorineural deafness, and thiamine-responsive anemia." | 7.72 | Novel mutation in the SLC19A2 gene in an African-American female with thiamine-responsive megaloblastic anemia syndrome. ( Calikoglu, AS; Lagarde, WH; Moats-Staats, BM; Underwood, LE, 2004) |
| "Thiamine-responsive megaloblastic anemia, also known as "TRMA" or "Rogers syndrome," is an early-onset autosomal recessive disorder defined by the occurrence of megaloblastic anemia, diabetes mellitus, and sensorineural deafness, responding in varying degrees to thiamine treatment." | 7.69 | Localization of the gene for thiamine-responsive megaloblastic anemia syndrome, on the long arm of chromosome 1, by homozygosity mapping. ( Barrett, T; Buist, N; Cohen, N; Fauré, S; Mandel, H; Neufeld, EJ; Raz, T; Stagg, A; Szargel, R; Yandava, CN, 1997) |
| "This case demonstrates Leber congenital amaurosis can present as the first clinical feature before systemic manifestations." | 5.72 | Leber congenital amaurosis as an initial manifestation in a Chinese patient with thiamine-responsive megaloblastic anemia syndrome. ( Sui, R; Sun, Z; Wu, S; Yao, F; Yuan, Z, 2022) |
| "Rogers syndrome is an autosomal recessive disorder resulting in megaloblastic anemia, diabetes mellitus, and sensorineural deafness." | 5.32 | Disruption of transport activity in a D93H mutant thiamine transporter 1, from a Rogers Syndrome family. ( Aronheim, A; Assaraf, YG; Baron, D; Drori, S, 2003) |
| "Wolfram syndrome, Kearns-Sayre syndrome, thiamine-responsive megaloblastic anemia, and maternally inherited diabetes and deafness are genetic disorders characterized by diabetes, impaired hearing, and vision." | 5.22 | Diabetes Out-of-the-Box: Diabetes Mellitus and Impairment in Hearing and Vision. ( Gruber, N; Pinhas-Hamiel, O, 2022) |
| "Thiamine-responsive megaloblastic anemia (TRMA), also known as Rogers syndrome, is a rare autosomal recessive disease characterized by three main components: megaloblastic anemia, diabetes mellitus and sensorineural deafness." | 5.01 | [Thiamine-responsive megaloblastic anemia or Rogers syndrome: A literature review]. ( Castioni, J; Lu, H; Tran, C; Vaucher, J; Vollenweider, P, 2019) |
| "Individuals with thiamine-responsive megaloblastic anemia (TRMA) mainly manifest macrocytic anemia, sensorineural deafness, ocular complications, and nonautoimmune diabetes." | 4.31 | An Italian case series' description of thiamine responsive megaloblastic anemia syndrome: importance of early diagnosis and treatment. ( Arrigoni, F; Bonfanti, R; Di Candia, F; Di Iorio, V; Fedi, L; Franzese, A; Iafusco, F; Iovino, C; Malesci, R; Mozzillo, E; Rigamonti, A; Rosanio, FM; Simonelli, F; Tinto, N, 2023) |
| " Thiamine supplementation corrected anemia and diabetes mellitus but did not improve the hearing defect." | 4.02 | Identification of novel compound heterozygous variants in SLC19A2 and the genotype-phenotype associations in thiamine-responsive megaloblastic anemia. ( Li, G; Qiao, Y; Shang, X; Sun, Y; Wang, Z; Zhang, S; Zhuang, J, 2021) |
| "Thiamine-responsive megaloblastic anemia (TRMA) syndrome is a rare disease comprising a classic triad of megaloblastic anemia, diabetes mellitus, and early-onset sensorineural deafness." | 3.91 | An Adult Case of Thiamine-Sensitive Megaloblastic Anemia Syndrome Accidentally Diagnosed Myelodysplastic Syndrome. ( Kutlucan, A, 2019) |
| "Thiamine-responsive megaloblastic anemia (TRMA) is a rare autosomal recessive inherited disease characterized by the clinical triad of megaloblastic anemia, sensorineural deafness, and diabetes mellitus." | 3.91 | TRMA syndrome with a severe phenotype, cerebral infarction, and novel compound heterozygous SLC19A2 mutation: a case report. ( Cheng, Q; Ding, Y; Li, Q; Li, X; Wang, J; Wang, X; Yao, R, 2019) |
| "Thiamine-responsive megaloblastic anemia (TRMA) syndrome is an autosomal recessive inherited disorder characterised by a triad of megaloblastic anemia, diabetes mellitus, and sensorineural deafness." | 3.88 | Thiamine Responsive Megaloblastic Anaemia, Diabetes Mellitus and Sensorineural Hearing Loss in a Child. ( Altaf, C; Fatima, S; Khadim, MT; Khurshid, A; Malik, HS; Sajjad, Z, 2018) |
| " Arrhythmia in thiamine responsive megaloblastic anemia syndrome." | 3.88 | Arrhythmia in thiamine responsive megaloblastic anemia syndrome. ( Akın, L; Argun, M; Baykan, A; Hatipoğlu, N; Kurtoğlu, S; Narin, N; Şahin, Y, 2018) |
| "Thiamine responsive megaloblastic anemia (TRMA) is characterized by a triad of megaloblastic anemia, non-type 1 diabetes mellitus and sensorineural deafness." | 3.80 | Thiamine responsive megaloblastic anemia: the puzzling phenotype. ( Al Zadjali, S; Alrawas, A; Bashir, W; Beshlawi, I; Elshinawy, M; Wali, Y, 2014) |
| "A female child presented with Leber's congenital amaurosis at 10 months of age, later diagnosed with hearing impairment at 1 year, diabetes mellitus and megaloblastic anemia at 3 and a half years of age and hence as a case of thiamine responsive megaloblastic anemia." | 3.80 | Leber's congenital amaurosis as the retinal degenerative phenotype in thiamine responsive megaloblastic anemia: a case report. ( Arokiasamy, T; Meenakshi, S; Murali, K; Soumittra, N; Srikrupa, NN, 2014) |
| "Thiamine-responsive megaloblastic anemia (TRMA) is an autosomal recessive syndrome characterized by early-onset anemia, diabetes, and hearing loss caused by mutations in the SLC19A2 gene." | 3.79 | Identification of a SLC19A2 nonsense mutation in Persian families with thiamine-responsive megaloblastic anemia. ( Ellard, S; Haghighi, A; Saleh-Gohari, N; Setoodeh, A, 2013) |
| "Thiamine-responsive megaloblastic anemia (TRMA) is a clinical triad characterized by megaloblastic anemia, non-autoimmune diabetes mellitus, and sensory-neural hearing loss." | 3.79 | Novel mutation in the SLC19A2 gene in an Iranian family with thiamine-responsive megaloblastic anemia: a series of three cases. ( Abbaszadegan, MR; Baradaran-Heravi, A; Ghaemi, N; Ghahraman, M; Vakili, R, 2013) |
| "The thiamine-responsive megaloblastic anemia syndrome (TRMA) is an autosomal recessive disorder characterized by diabetes mellitus, megaloblastic anemia and sensorineural hearing loss due to mutations in SLC 19A2 that encodes a thiamine transporter protein." | 3.78 | Thiamine-responsive megaloblastic anemia syndrome: a novel mutation. ( Aycan, Z; Bas, VN; Onder, A; Peltek Kendirci, HN; Yilmaz Agladioglu, S, 2012) |
| "Thiamine-responsive megaloblastic anaemia (TRMA; OMIM 249270) syndrome is an autosomal recessive disorder characterized by diabetes mellitus, megaloblastic anaemia, and sensorineural deafness." | 3.77 | Does early treatment prevent deafness in thiamine-responsive megaloblastic anaemia syndrome? ( Akın, L; Akın, MA; Karakükçü, M; Kendirci, M; Kurtoğlu, S, 2011) |
| "Thiamine-responsive megaloblastic anemia (TRMA) syndrome usually associated with diabetes mellitus, anemia and deafness, due to mutations in SLC19A2, encoding a thiamine transporter protein." | 3.76 | Thiamine-responsive megaloblastic anemia syndrome. ( Bay, A; Dai, A; Gumruk, F; Hizli, S; Keskin, M; Uygun, H, 2010) |
| "Thiamine responsive megaloblastic anemia syndrome (TRMA) is a clinical triad characterized by thiamine-responsive anemia, diabetes mellitus and sensorineural deafness." | 3.75 | Thiamine responsive megaloblastic anemia syndrome. ( Ezhilarasi, S; Ganesh, R; Gowrishankar, K; Rajajee, S; Vasanthi, T, 2009) |
| "This report describes a female child with thiamine responsive megaloblastic anemia syndrome (Rogers syndrome), presenting with anemia and diabetes mellitus responding to thiamine." | 3.75 | Thiamine responsive megaloblastic anemia. ( Mathews, L; Narayanadas, K; Sunil, G, 2009) |
| "Thiamine-responsive megaloblastic anemia is a rare autosomal recessive disorder whose main symptoms are anemia, diabetes mellitus, and sensorineural deafness." | 3.75 | Thiamine-responsive megaloblastic anemia syndrome: long term follow-up. ( Azzalli, M; Borgna-Pignatti, C; Pedretti, S, 2009) |
| "Thiamine-responsive megaloblastic anemia (TRMA) is a rare autosomal recessive disorder characterized by megaloblastic anemia, diabetes mellitus and progressive sensorineural deafness." | 3.75 | Diabetic acido-ketosis revealing thiamine-responsive megaloblastic anemia. ( Ben Mansour, F; Bouyahia, O; Khaldi, F; Matoussi, N; Ouderni, M, 2009) |
| "Thiamine-responsive megaloblastic anaemia (TRMA) is a rare autosomal recessive condition, characterized by megaloblastic anaemia, non-autoimmune diabetes mellitus, and sensorineural hearing loss." | 3.74 | Thiamine-responsive megaloblastic anaemia: a cause of syndromic diabetes in childhood. ( Hahnemann, JM; Olsen, BS; Schwartz, M; Østergaard, E, 2007) |
| "Thiamine-responsive megaloblastic anemia (TRMA) syndrome is an autosomal recessive disorder characterized by diabetes mellitus (DM), progressive sensorineural deafness, and thiamine-responsive anemia." | 3.72 | Novel mutation in the SLC19A2 gene in an African-American female with thiamine-responsive megaloblastic anemia syndrome. ( Calikoglu, AS; Lagarde, WH; Moats-Staats, BM; Underwood, LE, 2004) |
| "The triad of thiamine-responsive anaemia, diabetes mellitus and deafness has been reported in 15 patients with macrocytic anaemia, sometimes associated with moderate thrombocytopenia." | 3.70 | Thiamine-responsive myelodysplasia. ( Ayas, M; Bazarbachi, A; Haidar, JH; Muakkit, S; Salem, Z; Solh, H; Taher, A, 1998) |
| "Thiamine-responsive megaloblastic anemia, also known as "TRMA" or "Rogers syndrome," is an early-onset autosomal recessive disorder defined by the occurrence of megaloblastic anemia, diabetes mellitus, and sensorineural deafness, responding in varying degrees to thiamine treatment." | 3.69 | Localization of the gene for thiamine-responsive megaloblastic anemia syndrome, on the long arm of chromosome 1, by homozygosity mapping. ( Barrett, T; Buist, N; Cohen, N; Fauré, S; Mandel, H; Neufeld, EJ; Raz, T; Stagg, A; Szargel, R; Yandava, CN, 1997) |
| "Thiamine is a crucial cofactor involved in the maintenance of carbohydrate metabolism and participates in multiple cellular metabolic processes within the cytosol, mitochondria, and peroxisomes." | 2.61 | Genetic defects of thiamine transport and metabolism: A review of clinical phenotypes, genetics, and functional studies. ( Baide-Mairena, H; Marcé-Grau, A; Martí-Sánchez, L; Ortigoza-Escobar, JD; Pérez-Dueñas, B, 2019) |
| "Extremely rare cases of Wernicke encephalopathy (WE) can involve sensorineural hearing loss (SNHL)." | 1.91 | A Case of Sensorineural Hearing Loss in Wernicke Encephalopathy. ( Arivoli, K; Benvenuto, A; Stucken, E, 2023) |
| "This case demonstrates Leber congenital amaurosis can present as the first clinical feature before systemic manifestations." | 1.72 | Leber congenital amaurosis as an initial manifestation in a Chinese patient with thiamine-responsive megaloblastic anemia syndrome. ( Sui, R; Sun, Z; Wu, S; Yao, F; Yuan, Z, 2022) |
| "Rogers syndrome is an autosomal recessive disorder resulting in megaloblastic anemia, diabetes mellitus, and sensorineural deafness." | 1.32 | Disruption of transport activity in a D93H mutant thiamine transporter 1, from a Rogers Syndrome family. ( Aronheim, A; Assaraf, YG; Baron, D; Drori, S, 2003) |
| "Thiamine (75 mg/day) was commenced at a single oral dose with a rapid increase of Hb level after a few days of therapy." | 1.29 | [Wolfram syndrome. Personal experience]. ( Bizzarri, C; Conti, G; Falsini, B; Marietti, G; Perrone, F; Ricci, B; Zampino, G, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (7.02) | 18.7374 |
| 1990's | 5 (8.77) | 18.2507 |
| 2000's | 15 (26.32) | 29.6817 |
| 2010's | 25 (43.86) | 24.3611 |
| 2020's | 8 (14.04) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, S | 1 |
| Yuan, Z | 1 |
| Sun, Z | 1 |
| Yao, F | 1 |
| Sui, R | 1 |
| Gruber, N | 1 |
| Pinhas-Hamiel, O | 1 |
| Arivoli, K | 1 |
| Benvenuto, A | 1 |
| Stucken, E | 1 |
| Khaliq, S | 1 |
| Di Candia, F | 1 |
| Di Iorio, V | 1 |
| Tinto, N | 1 |
| Bonfanti, R | 1 |
| Iovino, C | 1 |
| Rosanio, FM | 1 |
| Fedi, L | 1 |
| Iafusco, F | 1 |
| Arrigoni, F | 1 |
| Malesci, R | 1 |
| Simonelli, F | 1 |
| Rigamonti, A | 1 |
| Franzese, A | 2 |
| Mozzillo, E | 2 |
| Tong, B | 1 |
| Niu, K | 1 |
| Ku, W | 1 |
| Xie, W | 1 |
| Dai, Q | 1 |
| Hellström, S | 1 |
| Duan, M | 1 |
| Nouira, N | 1 |
| Mansouri, R | 1 |
| Tlili, R | 1 |
| Bhouri, I | 1 |
| Sfaxi, S | 1 |
| Chtourou, D | 1 |
| Cheikh, MB | 1 |
| Zhang, S | 1 |
| Qiao, Y | 1 |
| Wang, Z | 1 |
| Zhuang, J | 1 |
| Sun, Y | 1 |
| Shang, X | 1 |
| Li, G | 1 |
| Xian, X | 1 |
| Lin, F | 1 |
| Habeb, AM | 1 |
| Flanagan, SE | 2 |
| Zulali, MA | 1 |
| Abdullah, MA | 1 |
| Pomahačová, R | 1 |
| Boyadzhiev, V | 1 |
| Colindres, LE | 1 |
| Godoy, GV | 1 |
| Vasanthi, T | 2 |
| Al Saif, R | 1 |
| Setoodeh, A | 2 |
| Haghighi, A | 4 |
| Shaalan, Y | 1 |
| Hattersley, AT | 1 |
| Ellard, S | 3 |
| De Franco, E | 1 |
| Lu, H | 2 |
| Vaucher, J | 1 |
| Tran, C | 1 |
| Vollenweider, P | 1 |
| Castioni, J | 1 |
| Khurshid, A | 1 |
| Fatima, S | 1 |
| Altaf, C | 1 |
| Malik, HS | 1 |
| Sajjad, Z | 1 |
| Khadim, MT | 1 |
| Argun, M | 1 |
| Baykan, A | 1 |
| Hatipoğlu, N | 1 |
| Akın, L | 2 |
| Şahin, Y | 1 |
| Narin, N | 1 |
| Kurtoğlu, S | 2 |
| Marcé-Grau, A | 1 |
| Martí-Sánchez, L | 1 |
| Baide-Mairena, H | 1 |
| Ortigoza-Escobar, JD | 1 |
| Pérez-Dueñas, B | 1 |
| Kutlucan, A | 1 |
| Dalwadi, P | 1 |
| Joshi, AS | 1 |
| Thakur, DS | 1 |
| Bhagwat, NM | 1 |
| Li, X | 1 |
| Cheng, Q | 1 |
| Ding, Y | 1 |
| Li, Q | 1 |
| Yao, R | 1 |
| Wang, J | 1 |
| Wang, X | 1 |
| Saleh-Gohari, N | 1 |
| Srikrupa, NN | 1 |
| Meenakshi, S | 1 |
| Arokiasamy, T | 1 |
| Murali, K | 1 |
| Soumittra, N | 1 |
| Ghaemi, N | 1 |
| Ghahraman, M | 1 |
| Abbaszadegan, MR | 1 |
| Baradaran-Heravi, A | 1 |
| Vakili, R | 1 |
| Beshlawi, I | 1 |
| Al Zadjali, S | 1 |
| Bashir, W | 1 |
| Elshinawy, M | 1 |
| Alrawas, A | 1 |
| Wali, Y | 1 |
| Liu, G | 1 |
| Yang, F | 1 |
| Han, B | 1 |
| Liu, J | 1 |
| Nie, G | 1 |
| Wood, MC | 1 |
| Tsiouris, JA | 1 |
| Velinov, M | 1 |
| Mikstiene, V | 1 |
| Songailiene, J | 1 |
| Byckova, J | 1 |
| Rutkauskiene, G | 1 |
| Jasinskiene, E | 1 |
| Verkauskiene, R | 1 |
| Lesinskas, E | 1 |
| Utkus, A | 1 |
| Gul, F | 1 |
| Muderris, T | 1 |
| Yalciner, G | 1 |
| Sevil, E | 1 |
| Bercin, S | 1 |
| Ergin, M | 1 |
| Babademez, MA | 1 |
| Kiris, M | 1 |
| Potter, K | 1 |
| Wu, J | 1 |
| Lauzon, J | 1 |
| Ho, J | 1 |
| Yeşilkaya, E | 1 |
| Bideci, A | 1 |
| Temizkan, M | 1 |
| Kaya, Z | 1 |
| Camurdan, O | 1 |
| Koç, A | 1 |
| Bozkaya, D | 1 |
| Koçak, U | 1 |
| Cinaz, P | 1 |
| Mathews, L | 1 |
| Narayanadas, K | 1 |
| Sunil, G | 1 |
| Ganesh, R | 1 |
| Ezhilarasi, S | 1 |
| Gowrishankar, K | 1 |
| Rajajee, S | 1 |
| Borgna-Pignatti, C | 1 |
| Azzalli, M | 1 |
| Pedretti, S | 1 |
| Bouyahia, O | 1 |
| Ouderni, M | 1 |
| Ben Mansour, F | 1 |
| Matoussi, N | 1 |
| Khaldi, F | 1 |
| Bay, A | 1 |
| Keskin, M | 1 |
| Hizli, S | 1 |
| Uygun, H | 1 |
| Dai, A | 1 |
| Gumruk, F | 1 |
| Kendirci, M | 1 |
| Akın, MA | 1 |
| Karakükçü, M | 1 |
| Kornienko, AM | 1 |
| Kornienko, RA | 1 |
| Antoniv, VF | 1 |
| Efimochkina, KV | 1 |
| Antoniv, TV | 1 |
| Popadiuk, VI | 1 |
| Kakupshev, AU | 1 |
| Yilmaz Agladioglu, S | 1 |
| Aycan, Z | 1 |
| Bas, VN | 1 |
| Peltek Kendirci, HN | 1 |
| Onder, A | 1 |
| Atanesian, AG | 1 |
| Kosiakov, SIa | 1 |
| Melis, D | 1 |
| Falco, M | 1 |
| Fattorusso, V | 1 |
| Taurisano, R | 1 |
| Oishi, K | 1 |
| Hofmann, S | 1 |
| Diaz, GA | 1 |
| Brown, T | 1 |
| Manwani, D | 1 |
| Ng, L | 1 |
| Young, R | 1 |
| Vlassara, H | 1 |
| Ioannou, YA | 1 |
| Forrest, D | 1 |
| Gelb, BD | 1 |
| NAKAHARA, K | 1 |
| KANEKO, Z | 1 |
| OSHITA, F | 1 |
| NIWA, O | 1 |
| YASUDA, Y | 1 |
| NUMAKURA, M | 1 |
| HONMA, T | 1 |
| ONUMA, M | 1 |
| Baron, D | 1 |
| Assaraf, YG | 1 |
| Drori, S | 1 |
| Aronheim, A | 1 |
| Lagarde, WH | 1 |
| Underwood, LE | 1 |
| Moats-Staats, BM | 1 |
| Calikoglu, AS | 1 |
| Manuĭlov, OE | 1 |
| Bezzubenko, LA | 1 |
| Buscaglia, J | 1 |
| Faris, J | 1 |
| Liberman, MC | 1 |
| Tartaglini, E | 1 |
| Fleming, JC | 1 |
| Neufeld, EJ | 2 |
| Alzahrani, AS | 1 |
| Baitei, E | 1 |
| Zou, M | 1 |
| Shi, Y | 1 |
| Olsen, BS | 1 |
| Hahnemann, JM | 1 |
| Schwartz, M | 1 |
| Østergaard, E | 1 |
| Pavlinec, O | 1 |
| Marietti, G | 1 |
| Bizzarri, C | 1 |
| Perrone, F | 1 |
| Zampino, G | 1 |
| Conti, G | 1 |
| Falsini, B | 1 |
| Ricci, B | 1 |
| Akinci, A | 1 |
| Teziç, T | 1 |
| Ertürk, G | 1 |
| Tarim, O | 1 |
| Dalva, K | 1 |
| Mandel, H | 1 |
| Raz, T | 1 |
| Szargel, R | 1 |
| Yandava, CN | 1 |
| Stagg, A | 1 |
| Fauré, S | 1 |
| Barrett, T | 1 |
| Buist, N | 1 |
| Cohen, N | 1 |
| Bazarbachi, A | 1 |
| Muakkit, S | 1 |
| Ayas, M | 1 |
| Taher, A | 1 |
| Salem, Z | 1 |
| Solh, H | 1 |
| Haidar, JH | 1 |
| Villa, V | 1 |
| Rivellese, A | 1 |
| Di Salle, F | 1 |
| Iovine, C | 1 |
| Poggi, V | 1 |
| Capaldo, B | 1 |
| Bappal, B | 1 |
| Nair, R | 1 |
| Shaikh, H | 1 |
| AI Khusaiby, SM | 1 |
| de Silva, V | 1 |
| Wolf, O | 1 |
| Hanson, J | 1 |
5 reviews available for thiamine and Hearing Loss, Sensorineural
| Article | Year |
|---|---|
Diabetes Out-of-the-Box: Diabetes Mellitus and Impairment in Hearing and Vision.
Topics: Anemia, Megaloblastic; Deafness; Diabetes Mellitus; Diabetes Mellitus, Type 2; Hearing; Hearing Loss | 2022 |
[Defect of thiamine transport and activation and related disease].
Topics: Anemia, Megaloblastic; Biological Transport; Diabetes Mellitus; Hearing Loss, Sensorineural; Humans; | 2018 |
[Thiamine-responsive megaloblastic anemia or Rogers syndrome: A literature review].
Topics: Anemia, Megaloblastic; Diabetes Mellitus; Diagnosis, Differential; Dietary Supplements; Hearing Loss | 2019 |
Genetic defects of thiamine transport and metabolism: A review of clinical phenotypes, genetics, and functional studies.
Topics: Anemia, Megaloblastic; Biological Transport; Biomarkers; Diabetes Mellitus; Hearing Loss, Sensorineu | 2019 |
A comprehensive study of oxidative stress in sudden hearing loss.
Topics: Adult; Biomarkers; Case-Control Studies; Dexamethasone; Disulfides; Female; Free Radical Scavengers; | 2017 |
2 trials available for thiamine and Hearing Loss, Sensorineural
| Article | Year |
|---|---|
Comparison of Therapeutic Results with/without Additional Hyperbaric Oxygen Therapy in Idiopathic Sudden Sensorineural Hearing Loss: A Randomized Prospective Study.
Topics: Adult; Aged; Audiometry, Pure-Tone; Combined Modality Therapy; Drugs, Chinese Herbal; Evoked Potenti | 2021 |
[Milgamma in the treatment of chronic neurosensory hypoacusis].
Topics: Adjuvants, Immunologic; Adult; Aged; Chronic Disease; Hearing Loss, Sensorineural; Humans; Middle Ag | 2004 |
50 other studies available for thiamine and Hearing Loss, Sensorineural
| Article | Year |
|---|---|
Leber congenital amaurosis as an initial manifestation in a Chinese patient with thiamine-responsive megaloblastic anemia syndrome.
Topics: Adolescent; Anemia, Megaloblastic; Child; China; Diabetes Mellitus; Hearing Loss, Sensorineural; Hum | 2022 |
A Case of Sensorineural Hearing Loss in Wernicke Encephalopathy.
Topics: Female; Hearing Loss, Sensorineural; Humans; Middle Aged; Thiamine; Thiamine Deficiency; Wernicke En | 2023 |
Thiamine responsive megaloblastic anaemia complicated with acute Parvovirus infection: A case report.
Topics: Adolescent; Anemia, Megaloblastic; Deafness; Diabetes Mellitus; Hearing Loss, Sensorineural; Humans; | 2023 |
An Italian case series' description of thiamine responsive megaloblastic anemia syndrome: importance of early diagnosis and treatment.
Topics: Adult; Anemia, Megaloblastic; Child; Deafness; Diabetes Mellitus; Early Diagnosis; Hearing Loss, Sen | 2023 |
Relapse of rare diseases during COVID-19 pandemic: bicytopenia in an adult patient with thiamine-responsive megaloblastic anaemia.
Topics: Acute Coronary Syndrome; Anemia, Megaloblastic; Betacoronavirus; Chest Pain; Coronavirus Infections; | 2020 |
Identification of novel compound heterozygous variants in SLC19A2 and the genotype-phenotype associations in thiamine-responsive megaloblastic anemia.
Topics: Anemia, Megaloblastic; Asia; Diabetes Mellitus; Genetic Association Studies; Hearing Loss, Sensorine | 2021 |
Pharmacogenomics in diabetes: outcomes of thiamine therapy in TRMA syndrome.
Topics: Alleles; Anemia, Megaloblastic; Child, Preschool; Cohort Studies; Diabetes Mellitus; Female; Genetic | 2018 |
Thiamine Responsive Megaloblastic Anaemia, Diabetes Mellitus and Sensorineural Hearing Loss in a Child.
Topics: Anemia, Megaloblastic; Blood Glucose; Child, Preschool; Diabetes Mellitus; Female; Glycated Hemoglob | 2018 |
Arrhythmia in thiamine responsive megaloblastic anemia syndrome.
Topics: Anemia, Megaloblastic; Arrhythmias, Cardiac; Child, Preschool; Diabetes Mellitus; Electrocardiograph | 2018 |
An Adult Case of Thiamine-Sensitive Megaloblastic Anemia Syndrome Accidentally Diagnosed Myelodysplastic Syndrome.
Topics: Adult; Anemia, Megaloblastic; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diagnosis | 2019 |
Neonatal diabetes mellitus: remission induced by novel therapy.
Topics: Administration, Oral; Anemia, Megaloblastic; Diabetes Mellitus; Diabetic Ketoacidosis; Female; Frame | 2019 |
TRMA syndrome with a severe phenotype, cerebral infarction, and novel compound heterozygous SLC19A2 mutation: a case report.
Topics: Adult; Anemia, Megaloblastic; Arrhythmias, Cardiac; Atrophy; Brain; Cerebral Infarction; Child; Diab | 2019 |
Identification of a SLC19A2 nonsense mutation in Persian families with thiamine-responsive megaloblastic anemia.
Topics: Anemia, Megaloblastic; Child; Child, Preschool; Codon, Nonsense; Diabetes Mellitus; Female; Genetic | 2013 |
Leber's congenital amaurosis as the retinal degenerative phenotype in thiamine responsive megaloblastic anemia: a case report.
Topics: Anemia, Megaloblastic; Diabetes Mellitus; Exons; Female; Hearing Loss, Sensorineural; Humans; Infant | 2014 |
Novel mutation in the SLC19A2 gene in an Iranian family with thiamine-responsive megaloblastic anemia: a series of three cases.
Topics: Anemia, Megaloblastic; Child, Preschool; Consanguinity; Diabetes Mellitus; Female; Hearing Loss, Sen | 2013 |
Thiamine responsive megaloblastic anemia: the puzzling phenotype.
Topics: Anemia, Megaloblastic; Diabetes Mellitus; Female; Hearing Loss, Sensorineural; Humans; Infant; Male; | 2014 |
Identification of four SLC19A2 mutations in four Chinese thiamine responsive megaloblastic anemia patients without diabetes.
Topics: Amino Acid Substitution; Anemia, Megaloblastic; Child; Child, Preschool; Diabetes Mellitus; DNA Muta | 2014 |
Recurrent psychiatric manifestations in thiamine-responsive megaloblastic anemia syndrome due to a novel mutation c.63_71 delACCGCTC in the gene SLC19A2.
Topics: Anemia, Megaloblastic; Diabetes Mellitus; Hearing Loss, Sensorineural; Humans; Ketoglutarate Dehydro | 2014 |
Thiamine responsive megaloblastic anemia syndrome: a novel homozygous SLC19A2 gene mutation identified.
Topics: Anemia, Megaloblastic; Base Sequence; Child, Preschool; Diabetes Mellitus; Hearing Loss, Sensorineur | 2015 |
Beta cell function and clinical course in three siblings with thiamine-responsive megaloblastic anemia (TRMA) treated with thiamine supplementation.
Topics: Anemia, Megaloblastic; Diabetes Mellitus; Female; Hearing Loss, Sensorineural; Humans; Infant; Infan | 2017 |
A novel mutation in the SLC19A2 gene in a Turkish female with thiamine-responsive megaloblastic anemia syndrome.
Topics: Anemia, Megaloblastic; Child, Preschool; Diabetes Mellitus; Diagnosis, Differential; Female; Genotyp | 2009 |
Thiamine responsive megaloblastic anemia.
Topics: Anemia, Megaloblastic; Child; Comorbidity; Diabetes Mellitus; Female; Hearing Loss, Sensorineural; H | 2009 |
Thiamine responsive megaloblastic anemia syndrome.
Topics: Anemia, Megaloblastic; Blood Glucose; Child, Preschool; Diabetes Mellitus, Type 1; Female; Follow-Up | 2009 |
Thiamine-responsive megaloblastic anemia syndrome: long term follow-up.
Topics: Anemia, Megaloblastic; Diabetes Mellitus; Female; Follow-Up Studies; Hearing Loss, Sensorineural; Hu | 2009 |
Diabetic acido-ketosis revealing thiamine-responsive megaloblastic anemia.
Topics: Anemia, Megaloblastic; Blood Cell Count; Bone Marrow Cells; Diabetes Mellitus; Diabetic Ketoacidosis | 2009 |
Thiamine-responsive megaloblastic anemia syndrome.
Topics: Anemia, Megaloblastic; Blood Component Transfusion; Bone Marrow; Diabetes Mellitus; Hearing Loss, Se | 2010 |
Does early treatment prevent deafness in thiamine-responsive megaloblastic anaemia syndrome?
Topics: Anemia, Megaloblastic; Diabetes Mellitus; Female; Hearing Loss, Sensorineural; Humans; Infant; Ketog | 2011 |
[Sensorineural hearing loss: New prospects for therapy].
Topics: Adjuvants, Immunologic; Administration, Oral; Aged; Audiometry; Disease Progression; Dose-Response R | 2011 |
[The importance of the pharmaceutical form and the routes of administration of B-group vitamins for the efficacious treatment of neurosensorial hearing loss].
Topics: Adult; Biopharmaceutics; Cochlear Nerve; Hearing Loss, Sensorineural; Humans; Male; Nerve Regenerati | 2012 |
Thiamine-responsive megaloblastic anemia syndrome: a novel mutation.
Topics: Anemia, Megaloblastic; Child, Preschool; Diabetes Mellitus; Diagnosis, Differential; Female; Follow- | 2012 |
[The role of neurotropic therapy in the treatment of acute sensorineural impairment of hearing following a viral infection].
Topics: Acute Disease; Adjuvants, Immunologic; Adult; Biological Availability; Cochlear Nerve; Drug Monitori | 2012 |
Thiamine responsive megaloblastic anemia: a novel SLC19A2 compound heterozygous mutation in two siblings.
Topics: Adult; Anemia, Megaloblastic; Child; Child, Preschool; Diabetes Mellitus; Female; Hearing Loss, Sens | 2013 |
Targeted disruption of Slc19a2, the gene encoding the high-affinity thiamin transporter Thtr-1, causes diabetes mellitus, sensorineural deafness and megaloblastosis in mice.
Topics: Anemia, Megaloblastic; Animals; Bone Marrow; Brain; Diabetes Mellitus; DNA Primers; Erythrocytes; Ge | 2002 |
[2 CASES OF SLIGHT PERCEPTIVE DEAFNESS CURED BY ASPARA TABLETS].
Topics: Aspartic Acid; Chondroitin; Deafness; Hearing Loss; Hearing Loss, Sensorineural; Humans; Tablets; Th | 1963 |
[The use of sugarcoated alinamin in massive doses in the treatment of inner ear deafness and tinnitus aurium].
Topics: Deafness; Ear, Inner; Hearing Loss; Hearing Loss, Sensorineural; Humans; Thiamine; Tinnitus | 1962 |
[Experience in the use of ATP-2Na (Adephos KOWA) in inner ear deafness and tinnitus].
Topics: Adenine Nucleotides; Adenosine Triphosphate; Deafness; Ear, Inner; Hearing Loss; Hearing Loss, Senso | 1962 |
Disruption of transport activity in a D93H mutant thiamine transporter 1, from a Rogers Syndrome family.
Topics: Amino Acid Sequence; Anemia, Megaloblastic; Animals; Aspartic Acid; Biological Transport; Cell Line; | 2003 |
Novel mutation in the SLC19A2 gene in an African-American female with thiamine-responsive megaloblastic anemia syndrome.
Topics: Anemia, Megaloblastic; Black or African American; Diabetes Mellitus; DNA Mutational Analysis; Female | 2004 |
Unsteady, unfocused, and unable to hear.
Topics: Adolescent; Cognition Disorders; Combined Modality Therapy; Female; Fluid Therapy; Gait Disorders, N | 2005 |
Deletion of SLC19A2, the high affinity thiamine transporter, causes selective inner hair cell loss and an auditory neuropathy phenotype.
Topics: Animals; Auditory Perception; Hair Cells, Auditory, Inner; Hearing Loss, Sensorineural; Membrane Tra | 2006 |
Thiamine transporter mutation: an example of monogenic diabetes mellitus.
Topics: Adolescent; Anemia, Megaloblastic; Diabetes Mellitus, Type 1; Female; Hearing Loss, Sensorineural; H | 2006 |
Thiamine-responsive megaloblastic anaemia: a cause of syndromic diabetes in childhood.
Topics: Anemia, Megaloblastic; Child, Preschool; Consanguinity; Diabetes Complications; Diabetes Mellitus; D | 2007 |
[Can severe hearing damage after epidemic parotitis be prevented?].
Topics: Child; Child, Preschool; Female; Hearing Loss, Sensorineural; Humans; Mumps; Thiamine; Vasodilator A | 1982 |
[Wolfram syndrome. Personal experience].
Topics: Autoantibodies; Child, Preschool; Diabetes Mellitus, Type 1; Female; Hearing Loss, Sensorineural; Hu | 1995 |
Thiamine-responsive megaloblastic anemia with diabetes mellitus and sensorineural deafness.
Topics: Anemia, Megaloblastic; Diabetes Mellitus, Type 1; Female; Follow-Up Studies; Hearing Loss, Sensorine | 1993 |
Localization of the gene for thiamine-responsive megaloblastic anemia syndrome, on the long arm of chromosome 1, by homozygosity mapping.
Topics: Alaska; Anemia, Megaloblastic; Arabs; Chromosome Mapping; Chromosomes, Human, Pair 1; Consanguinity; | 1997 |
Thiamine-responsive myelodysplasia.
Topics: Child; Child, Preschool; Diabetes Mellitus, Type 1; Female; Hearing Loss, Sensorineural; Humans; Mal | 1998 |
Acute ischemic stroke in a young woman with the thiamine-responsive megaloblastic anemia syndrome.
Topics: Adult; Anemia, Megaloblastic; Angiography; Diabetes Mellitus, Type 1; Female; Hearing Loss, Sensorin | 2000 |
Five years followup of diabetes mellitus in two siblings with thiamine responsive megaloblastic anemia.
Topics: Abnormalities, Multiple; Anemia, Megaloblastic; Blood Glucose; Diabetes Mellitus; Female; Follow-Up | 2001 |
[Results of multistep oxygen therapy in the treatment of sudden hearing loss].
Topics: Adult; Combined Modality Therapy; Dipyridamole; Drug Combinations; Drug Therapy, Combination; Female | 1991 |